Major Depressive Disorder
Conditions
Brief summary
The primary outcomes are the association between medication induced changes in gut microbial profile, depression symptoms and side effects
Detailed description
A secondary outcome is the role of therapeutic blood plasma levels (reflecting drug absorption) in the association between medication-induced changes in the gut microbial profile and treatment efficacy.
Interventions
DRUGVENLAFAXINE
Sponsors
Radboud universitair medisch centrum Stichting
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes are the association between medication induced changes in gut microbial profile, depression symptoms and side effects | — |
Secondary
| Measure | Time frame |
|---|---|
| A secondary outcome is the role of therapeutic blood plasma levels (reflecting drug absorption) in the association between medication-induced changes in the gut microbial profile and treatment efficacy. | — |
Countries
Netherlands
Outcome results
None listed